| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494526A Inhibitor of monoamine uptake |
| 05/05/2004 | CN1494430A Modified protamine with reduced immunogenicity |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1493684A New acid resistant and cholate resistant lactobacillus isolated strain having reducing and assimilating cholesterol ability |
| 05/05/2004 | CN1493560A Compond for implementing methionine and calcium and its production method |
| 05/05/2004 | CN1493347A Chinese medicine for reducing body weight and fat and its making method |
| 05/05/2004 | CN1493321A Chinese medicine composition for treating diabetes |
| 05/05/2004 | CN1493318A Chinese medicine for treating diabetes |
| 05/05/2004 | CN1493298A Ginseng stem leaf total saponin drip pill and its preparation method |
| 05/05/2004 | CN1493286A Drip pill medicine composition for treating diabetes and its complication and productive method thereof |
| 05/05/2004 | CN1493276A Ferulaic acid sodium drip pill and its preparation method |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148208C Medicine for curing diabetes and its producing process |
| 05/05/2004 | CN1148195C Trace element preparation for livestock and fowl and its preparation method |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/05/2004 | CN1148179C 20-Hete antagonists and agonists |
| 05/05/2004 | CN1148178C Mixtures separated from seeds of syzygium, preparations thereof, and uses as medicines containing them and components therefrom |
| 05/05/2004 | CN1148176C Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730706 Treatments using venlafaxine |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730693 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730687 Therapy of metabolic diseases such as diabetes and hyperlipidemia as agonists of peroxisome proliferator-activated receptor |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730674 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 05/04/2004 | US6730661 Non-digestible dextrans, hydrolysed (galacto)mannans and/or hydrolysed (gluco)mannans; reduce the uptake of high molecular weight substances, allergens and microorganisms through the intestinal wall |
| 05/04/2004 | US6730324 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 05/04/2004 | US6730319 Pharmaceutical compositions having depressed melting points |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2110442C Process for obtaining proinsulin possessing correctly linked cystine bridges |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035740A2 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035552A1 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof |
| 04/29/2004 | WO2004035550A1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 04/29/2004 | WO2004035082A2 Proteins involved in the regulation of energy homeostasis |
| 04/29/2004 | WO2004035074A1 Composition for lowering blood glucose level comprising extract of natural product |
| 04/29/2004 | WO2004035069A1 Pharmaceutical antidiabetic composition |
| 04/29/2004 | WO2004035065A1 Hypoglycemic substances containing zinc |
| 04/29/2004 | WO2004035040A1 Enhancement of alcohol metabolism |
| 04/29/2004 | WO2004035025A1 Agent for oral administration, containing a tablet made of konjac flour and which is insoluble or poorly soluble in water or in a gastrointestinal medium |
| 04/29/2004 | WO2004034965A2 Method for treating cancer |
| 04/29/2004 | WO2004022772A3 Modulation of the synthesis of insulin |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004016101A3 Compositions comprising dietary fat complexer and methods for their use |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003082798A8 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002064134A8 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082666 Antiserotonine agents |
| 04/29/2004 | US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines |
| 04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
| 04/29/2004 | US20040082636 Method for the prophylaxis or treatment of glomerulonephritis |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082620 Antidiabetic agents |
| 04/29/2004 | US20040082603 2,3-Dihydro-isoindol-1-one derivatives |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081712 Soy protein, phytoestrogens and dietary fibres and compositions |
| 04/29/2004 | US20040081711 alpha-Glucosidase inhibitors from a natural source |
| 04/29/2004 | US20040081693 Capable of releasing the drug at a constant rate following zero order kinetics for 24 hours or more |